# OnCo record abalos-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/abalos-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "abalos-therapeutics" ;
  schema:name "Abalos Therapeutics"@en ;
  schema:description "Abalos Therapeutics is testing a modified virus, given into a vein, that is designed to switch on the immune system inside tumours without destroying the infected cells. Its first medicine, ABX-001, is in an early trial for people with advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/abalos-therapeutics/>, <https://abalos-tx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://abalos-tx.com/>, <https://abalos-tx.com/wp-content/uploads/2025/10/20251023_Abalos_PR_FPI_ABX-001_Final.pdf>, <https://clinicaltrials.gov/study/NCT07231458> ;
  schema:addressCountry "DE" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> .